Skip to main content
. 2024 Mar 20;16:25158414241232258. doi: 10.1177/25158414241232258

Figure 3.

Figure 3.

Medications that reduce the often-coexisting allergic and ocular symptoms in KC patients.13,52,53

GPC, giant papillary conjunctivitis; H1, histamine H1 receptor; H2, histamine H2 receptor; SRS-A, slow-reacting substance of anaphylaxis.